Control of the physical form of salmeterol xinofoate

被引:59
作者
Beach, S
Latham, D
Sidgwick, C
Hanna, M
York, P
机构
[1] Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Stevenage SG1 2NY, Herts, England
[2] Bradford Particle Design, Bradford BD7 1HR, W Yorkshire, England
[3] Univ Bradford, Sch Pharm, Drug Delivery Grp, Bradford BD7 1DP, W Yorkshire, England
关键词
D O I
10.1021/op990160z
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Two approaches to the generation of particles of the phenethanolamine, salmeterol xinafoate, are discussed. To produce particles with good flow properties a fast cooling crystallisation process was developed which delivered salmeterol xinafoate as spherical agglomerates of microcrystals which had good powder flow characteristics and could be micronised efficiently in a fluid energy mill. In a radically different approach, salmeterol xinafoate was crystallised using supercritical carbon dioxide in the SEDS (solution enhanced dispersion by supercritical fluids) process. By means of this technique the solid state form, crystal habit, and particle size of salmeterol xinafoate could be effectively controlled.
引用
收藏
页码:370 / 376
页数:7
相关论文
共 14 条
[1]  
*ACS, 1989, ACS SYM SER, V406, P335
[2]  
ATKINS PJ, 1992, DESING DEV INHALATIO
[3]  
AULTON ME, 1988, PHARM SCI DOSAGE FOR
[4]   AEROSOL SOLVENT-EXTRACTION SYSTEM - A NEW MICROPARTICLE PRODUCTION TECHNIQUE [J].
BLEICH, J ;
MULLER, BW ;
WASSMUS, W .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 97 (1-3) :111-117
[5]   INFLUENCE OF GAS-DENSITY AND PRESSURE ON MICROPARTICLES PRODUCED WITH THE ASES PROCESS [J].
BLEICH, J ;
KLEINEBUDDE, P ;
MULLER, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 106 (01) :77-84
[6]   PHYSICAL CHARACTERIZATION OF PHARMACEUTICAL SOLIDS [J].
BRITTAIN, HG ;
BOGDANOWICH, SJ ;
BUGAY, DE ;
DEVINCENTIS, J ;
LEWEN, G ;
NEWMAN, AW .
PHARMACEUTICAL RESEARCH, 1991, 8 (08) :963-973
[7]  
Carr R.L., 1965, Chem. Eng, V72, P163, DOI DOI 10.1016/J.JAEROSCI.2007.10.003
[8]  
DOBSON B, 1969, POWDER TECHNOL, V3, P213
[9]  
Lachman L, 1986, THEORY PRACTICE IND
[10]   EVALUATION OF SUPERCRITICAL FLUID EXTRACTION IN THE PHARMACEUTICAL-INDUSTRY [J].
LARSON, KA ;
KING, ML .
BIOTECHNOLOGY PROGRESS, 1986, 2 (02) :73-82